|
|
Office Locations:
|
53 State Street
Boston, MA 02109
Phone: 617-834-6576
| | |
|
|
|
|
|
Life Sciences & Healthcare
Medical Device
|
|
|
|
Kendall Capital Partners invests in early stage companies that are incubated by scientific labs from top universities, upholding the concept of 'value creation' with commitment to support entrepreneurs using the firm's extensive network of resources. Target industries include Biotechnology, Novel Drug, Diagnostics, and Drug Delivery.
|
|
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
